Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy?
Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy?
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI
Subjects
More information
Scope and Contents
Contents
Background: Aromatase inhibitors (AI) are widely used for treating hormone-sensitive breast cancer (BC). Obesity, however, due to aromatase-mediated androgen conversion into estradiol in the peripheral adipose tissue, might impair AI inhibitory capacity. We aimed at identifying a cut-off of body mass index (BMI) with significant prognostic impact,...
Alternative Titles
Full title
Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_710140592e9c4a799d00a6c215e557d7
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_710140592e9c4a799d00a6c215e557d7
Other Identifiers
ISSN
1718-7729,1198-0052
E-ISSN
1718-7729
DOI
10.3390/curroncol30010094
